On the contrary, some studies showed that AChE inhibitors reduce the cognitive disturbance in AD and recommend it as an alternate therapeutic component (Noedberg 2006; Recanatini & Valenti 2004). This evidence concerns the gene ACHE and Alzheimer disease.